Lentivirus-based virus-like particles as a new protein delivery tool
- PMID: 20225039
- DOI: 10.1007/978-1-60761-533-0_7
Lentivirus-based virus-like particles as a new protein delivery tool
Abstract
Virus Like Particles (VLPs) are self-assembling, nonreplicating, nonpathogenic, genomeless particles similar in size and conformation to intact infectious virions. The possibility of engineering VLPs to incorporate heterologous polypeptides/proteins renders VLPs attractive candidates for vaccine strategies, as well as for protein delivery for basic science. Among the wide number of VLP types, our expertise focused on both retro- and lentivirus based VLPs as protein delivery tools. In particular, here we describe a system relying on the finding that some HIV-1 Nef mutants are incorporated at high levels into both Human Immunodeficiency virus (HIV)-1 and Moloney Leukemia Virus (MLV)-based VLPs. Most importantly, these Nef mutants can efficiently act as anchoring proteins upon fusion with heterologous proteins up to 630 amino acids in length. This chapter describes the preparation of prototypic HIV-1 based VLPs incorporating Nef mutant-GFP fusion molecules. Besides having potential utility in the field of basic virology, these VLPs represent a useful reference model for recovering alternative retro- or lentiviral based VLPs for the cell delivery of polypeptides/proteins of interest.
Similar articles
-
Cell death induced by the herpes simplex virus-1 thymidine kinase delivered by human immunodeficiency virus-1-based virus-like particles.Mol Ther. 2005 Dec;12(6):1185-96. doi: 10.1016/j.ymthe.2005.06.474. Epub 2005 Aug 10. Mol Ther. 2005. PMID: 16095973
-
A strategy of antigen incorporation into exosomes: comparing cross-presentation levels of antigens delivered by engineered exosomes and by lentiviral virus-like particles.Vaccine. 2012 Nov 26;30(50):7229-37. doi: 10.1016/j.vaccine.2012.10.010. Epub 2012 Oct 22. Vaccine. 2012. PMID: 23099330
-
Selective elimination of HIV-1-infected cells by Env-directed, HIV-1-based virus-like particles.Virology. 2006 Feb 5;345(1):115-26. doi: 10.1016/j.virol.2005.09.054. Epub 2005 Nov 4. Virology. 2006. PMID: 16271741
-
The use of virus-like particles for gene transfer.Curr Opin Mol Ther. 2003 Oct;5(5):524-8. Curr Opin Mol Ther. 2003. PMID: 14601522 Review.
-
Papillomavirus virus-like particles as vehicles for the delivery of epitopes or genes.Arch Virol. 2006 Nov;151(11):2133-48. doi: 10.1007/s00705-006-0798-8. Epub 2006 Jun 22. Arch Virol. 2006. PMID: 16791442 Review.
Cited by
-
Optimization of a Soft Ensemble Vote Classifier for the Prediction of Chimeric Virus-Like Particle Solubility and Other Biophysical Properties.Front Bioeng Biotechnol. 2020 Jul 31;8:881. doi: 10.3389/fbioe.2020.00881. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32850736 Free PMC article.
-
Production and Use of Gesicles for Nucleic Acid Delivery.Mol Biotechnol. 2022 Mar;64(3):278-292. doi: 10.1007/s12033-021-00389-6. Epub 2021 Oct 1. Mol Biotechnol. 2022. PMID: 34596870
-
Vaccine Development Against COVID-19 Prior to Pandemic Outbreaks, Using in vitro Evolution and Reverse Genetics.Front Immunol. 2020 Aug 14;11:2051. doi: 10.3389/fimmu.2020.02051. eCollection 2020. Front Immunol. 2020. PMID: 32922408 Free PMC article. No abstract available.
-
Endogenous CCL2 neutralization restricts HIV-1 replication in primary human macrophages by inhibiting viral DNA accumulation.Retrovirology. 2015 Jan 22;12:4. doi: 10.1186/s12977-014-0132-6. Retrovirology. 2015. PMID: 25608886 Free PMC article.
-
Delivering SaCas9 mRNA by lentivirus-like bionanoparticles for transient expression and efficient genome editing.Nucleic Acids Res. 2019 May 7;47(8):e44. doi: 10.1093/nar/gkz093. Nucleic Acids Res. 2019. PMID: 30759231 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources